Kezar Life Sciences (KZR): Narx-foyda va o‘sish multiplikatori
Kezar Life Sciences (KZR) biotexnologiya siklining eng past nuqtasida xarajatlarni optimallashtirmoqda va likvidlikni ustuvor ishlanmalarga yo'naltirmoqda. Yetakchi immunologlardan iborat jamoa akademik erkinlikdan foydalangan holda autoimmun patologiyalar uchun innovatsion davolash usullarini yaratmoqda. PEG koeffitsiyenti biznesning bozor qiymatini vizuallashtiradi, bunda joriy ko'rsatkich 0.00 ni tashkil etadi. Nefrit terapiyasida zetomipzomibning muvaffaqiyati, grafikdagi narx harakatlari bilan tasdiqlanganidek, ushbu aktivni sog'liqni saqlash giganti uchun strategik jihatdan qimmatli qiladi.
Kezar Life Sciences Inc (KZR) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- birja kapitallashuvi ma'lumotlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Qarzning xususiy kapitalga nisbati Kezar Life Sciences|KZR - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati Kezar Life Sciences Inc.|KZR - Kompaniya qarzlari|Balans kapitallashuviga qarzlar Kezar Life Sciences Inc|KZR - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Kezar Life Sciences|Kritik likvidlik koeffitsiyenti kezarlifesciences.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
KZR - Sof foyda|Prognoz qilingan kelajakdagi foyda Kezar Life Sciences|KZR - Narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori Kezar Life Sciences, Inc.|KZR - Narx-foyda va o‘sish multiplikatori|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati Kezar Life Sciences|KZR - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foyda Kezar Life Sciences|KZR - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik o'zgarishi kezarlifesciences.com|KZR - Joriy yilda foyda o'sishi|Kelgusi yil uchun bir aksiya uchun sof foydaning o'zgarishi prognozi Kezar Life Sciences
- sotishdan tushum va biznes daromadlari ko'rsatkichlari:
Kompaniyaning fundamental tahlili:KZR Kezar Life Sciences, Inc
Uzoq muddatli investitsiyalar aktiv qiymatining kengayish sur'atlari bilan qat'iy muvofiqligini talab qiladi. Bu Kezar Life Sciences (KZR) uchun juda muhimdir, chunki autoimmun kasalliklar terapiyalariga bo'lgan talab bozor sikllaridan mustaqil qolmoqda. PEG koeffitsiyentini tahlil qilish orqali biz kapitalizatsiya samaradorligini foyda o'sishiga nisbatan baholaymiz. Birga solishtirganda pastroq qiymat biznesning qadrsizlanganini anglatadi. Bunday profil istiqbolli biotexnologik aktivlarni ko'rsatadi.
Raqobatdosh kompaniyalar
ARGX (Argenx) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (biontech.de)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax S.A. (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|Protagonist Therapeutics, Inc. (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant Therapeutics (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori adaptivebiotech.com|Narxning foydaga va o‘sish sur’atiga nisbati Celldex (CLDX)|Aurinia Pharmaceuticals Inc. - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (biocryst.com)|Vera Therapeutics, Inc. (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|Dianthus Therapeutics, Inc. - PEG multiplikatori|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati PHVS|ABCL: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Tourmaline Corp (TRML)|PGEN (precigen.com) - PEG multiplikatori|PEG multiplikatori Pharming Corp|Narx-foyda va o‘sish multiplikatori NKTR (Nektar)|UPB (Upstream Bio Inc) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Zenas Bio ZBIO|IMNM: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|GOSS - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati KalVista Pharmaceuticals KALV|Septerna (SEPN) - Narxning foydaga va o‘sish sur’atiga nisbati|pieris.com - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|SVRA (Savara Inc) - PEG multiplikatori|RIGL: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ANAB|ATXS (Astria Pharma) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati enGene Holdings Inc. ENGN|PEG multiplikatori RAPT Therapeutics Inc. RAPT|Aerovate Therapeutics - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Aclaris Therapeutics Inc.|Kyverna (KYTX) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda Tiziana Life Sciences (TLSA)|Narxning foydaga va o‘sish sur’atiga nisbati Cabaletta Bio Inc.|Ventyx Biosciences (VTYX) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PEG multiplikatori THTX|PEG multiplikatori Avalo Therapeutics Inc. (AVTX)|PEG multiplikatori ELDN (eledon.com)|AGEN - Narx-foyda va o‘sish multiplikatori|CLYM: Narx-foyda va o‘sish multiplikatori|ZURA (Zura Bio Limited) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|ATYR: PEG multiplikatori|Adagene (ADAG) - PEG multiplikatori|IMA (ikenaoncology.com) - PEG multiplikatori|shattucklabs.com (STTK) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Equillium Inc (EQ)|Connect Pharma - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Immunic, Inc. IMUX|ATRA - Narx-foyda va o‘sish multiplikatori|IFRX - Narxning foydaga va o‘sish sur’atiga nisbati|XFOR: Narxning foydaga va o‘sish sur’atiga nisbati|ACET: PEG multiplikatori|Celularity Corp (CELU) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati INmune Bio|Barinthus Biotherapeutics plc (BRNS) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati SAB Biotherapeutics, Inc. (SABS)|AKTX (Akari Therapeutics plc) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Enlivex Therapeutics Ltd ENLV|QTTB - Narx-foyda va o‘sish multiplikatori|geovax.com - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti EDSA (Edesa Biotech Inc)|IBIO: PEG multiplikatori|Carisma Tx (CARM) - PEG multiplikatori|XTLB (XTL Biopharmaceuticals) - PEG multiplikatori|BOLT: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narx-foyda va o‘sish multiplikatori HCWB (HCW Biologics, Inc.)|PEG multiplikatori Aptevo (APVO)|PEG multiplikatori AIM (aimimmuno.com)|PEG multiplikatori Aditxt Corp ADTX|GRI: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti XRTX (xortx.com)|Vyome Holdings Inc. (HIND) - Narxning foydaga va o‘sish sur’atiga nisbati|Revelation Bio (REVB) - PEG multiplikatori|INDP (Indaptus Corp) - PEG multiplikatori|SCNI: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori CALI|Narx-foyda va o‘sish multiplikatori Affimed N.V. AFMD|Narxning foydaga va o‘sish sur’atiga nisbati Allakos ALLK|HOOK: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|IGMS - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati iTeos Therapeutics ITOS|Ocean Biomedical (OCEA) - Narxning foydaga va o‘sish sur’atiga nisbati|tcbiopharm.com (TCBP) - PEG multiplikatori|THRD (Third Harmonic Bio Inc.) - PEG multiplikatori
